This rising demand collides with real operational constraints, such as credentialed technologists and physician shortages, aging equipment, getting out in front of evolving billing codes in 2026, and the modifications needed for the type of HST devices utilized, fragmented software, EMR integration requirements, capital constraints, and pressure to expand home‑based testing.
Hospitals are not outsourcing sleep because the specialty is shrinking; they are outsourcing to maintain and grow while reducing operational burden and modernizing infrastructure. Hospital executive teams are looking for partners that can expand diagnostic volume, modernize technology, support both in‑lab and home testing, and strengthen physician alignment while improving margins. In larger systems, the ability to reliably staff thousands of annual procedures and develop a sustainable workforce is an essential requirement, not a luxury.
For hospital leadership, the issue is not simply diagnostic testing—it is revenue integrity across the patient pathway. When referrals move into external diagnostic networks, the hospital may lose not only the sleep study itself, but also the downstream cardiology, pulmonary, and chronic disease services that follow.
Two Competing Management Service Models
Model A: Distributed, external referral networks
Some companies are growing through consolidated vendor models that contract with hospitals to provide services and by prioritizing referral channels outside the hospital ecosystem, directly with physician groups.
These programs typically emphasize:
- Direct acquisition of referrals from community physician groups.
- Home‑based diagnostic pathways that operate outside of hospital programs.
- Multi‑channel marketing and direct‑to‑consumer patient acquisition.
- Vertically integrated testing, interpretation by remote physician coverage (“Doc-in-a-Box”), and therapy networks.
While these models can expand access to home sleep testing, they may also pull patients out of the hospital’s ecosystem. When a patient enters an external diagnostic network, the hospital risks losing technical and professional sleep revenue, visibility into the patient’s pathway, and downstream cardiology and procedural opportunities associated with that patient. The practical question for executives is: when sleep testing is controlled by an external network, who ultimately captures the clinical and financial value generated by that patient?
Model B: Hospital‑aligned growth models
In contrast, hospital‑aligned partners are modeled to keep the patient pathway anchored inside the health system.
These models focus on:
- Directing referrals into hospital‑branded sleep pathways.
- Expanding clinical capabilities within the institution (in‑lab and the ability to provide agnostic home testing equipment to meet evolving reimbursement codes and patient clinical needs under the hospital and its medical director’s oversight).
- Integrating technology, data, and reporting into the hospital EMR, cardiology, and DME workflows.
- Structuring incentives so that growth in sleep diagnostics drives growth in hospital service lines.
In these partnerships, diagnostic testing, physician interpretation, and integration with downstream care remain within the hospital’s program rather than being diverted to external networks. As a result, sleep becomes a growth engine for hospital‑owned cardiology, pulmonary, and metabolic programs instead of a leakage point.
The Defining Issue: Who Owns the Pathway?
For hospital leaders, the central issue is not simply who runs the lab or supplies the home tests; it is who controls the patient pathway from suspicion of sleep disease through diagnosis, therapy, compliance, and cardiometabolic follow‑up. Control of that pathway determines diagnostic revenue, procedural capture, physician alignment, and long‑term strategic positioning in chronic disease management. When referral relationships and diagnostic programs are routed through external networks, hospitals lose visibility into where patients are tested, how they are treated, and where high‑value cardiac and metabolic procedures ultimately occur.
In a hospital‑aligned partnership model, incentives are structured so that patient acquisition, testing, interpretation, and therapy coordination all reinforce the hospital’s role as the hub of care. This alignment ensures stability of the sleep program while protecting and expanding downstream service lines.
Integrated Technology as the Key Differentiator
Hospitals are increasingly distinguishing between vendors that provide basic operational services and partners that deliver true high-value partnerships that offer:
- Advanced diagnostic devices for both in‑lab and home sleep testing.
- Interoperable software platforms and robust EMR connectivity.
- Cross‑department data visibility and analytics.
- Workflow automation using AI‑enabled tools.
Hospital-aligned partners enable patient management capabilities that span across multiple treatments—including CPAP therapy, compliance monitoring, cardiology, chronic disease management, and more—providing referring physicians with full visibility into the entire continuum of care.
This level of integration is becoming a primary driver of growth in hospital sleep medicine because it allows sleep data to trigger targeted cardiology and chronic disease interventions rather than remaining a siloed diagnostic report. In these models, the question is no longer “who performs the test,” but “who equips the hospital with the technology to manage high‑risk patients across the continuum of care.”
Turning Sleep Into a Downstream Procedure Growth Engine
Forward‑looking hospital partnerships are now using sleep data to activate structured clinical pathways. Emerging platforms can derive risk indications directly from in‑lab and home sleep testing signals, identify patterns suggestive of cardiac issues, and flag high‑risk patients in real time for a designated care team. Those flags can trigger standardized follow‑up, such as ambulatory cardiac monitoring, echocardiography, stress testing, and electrophysiology consultation, all within the hospital.
When these workflows are owned by the hospital, sleep programs become enterprise engines for multiple service lines. Hospitals respond strongly to this model because it keeps patients in‑network, expands procedural opportunities, and supports population‑health and cardiometabolic initiatives, thereby enhancing long‑term revenue capture.
Closing the Loop: CPAP Therapy and Compliance Management
For patients diagnosed with obstructive sleep apnea, the value of a hospital‑aligned model extends beyond diagnosis into treatment and long‑term adherence to CPAP therapy. Continuous positive airway pressure remains the gold‑standard treatment for OSA, but long‑term adherence is challenging, with fewer than half of patients achieving high, sustained use without structured support. Hospitals that own the sleep pathway are uniquely positioned to pair device setup, education, and follow‑up with chronic disease and cardiology programs, turning CPAP adherence into a lever for reducing cardiovascular risk.
In a hospital‑aligned model, CPAP compliance workflows are embedded within the health system rather than sitting with an external DME network.
By keeping CPAP provisioning, monitoring, and compliance management exclusively inside the hospital ecosystem, sleep programs complete the loop from diagnosis to durable therapy, while supporting cardiology, stroke, and metabolic risk‑reduction goals across the enterprise.
Questions for Hospital Decision‑Makers
As health systems evaluate potential partners, several strategic questions should guide the decision:
- Who controls patient acquisition into the sleep pathway—the consolidated vendor model or the hospital-aligned partner?
- Where does downstream cardiology and procedural revenue ultimately flow?
- Does the proposed model reinforce your service lines, or does it gradually redirect value outside the system?
- Are incentives fully aligned with your growth, physician alignment, and long‑term positioning in cardiometabolic care?
- Does the technology platform integrate with your EMR, cardiology service line, and your chronic disease programs?
The key question for C-level hospital decision-makers in a rapidly evolving healthcare ecosystem is which model is in the hospital’s best interest on a short- and long-term basis. The most durable partnerships in sleep medicine are no longer defined by who owns the bed or ships the home device. They are defined by those who enable the hospital to retain ownership of the patient pathway while expanding clinical reach, cardiometabolic outcomes, and downstream revenue.
Mandy Perry, RPSGT, is an operations manager with more than a decade of experience in sleep medicine. Since entering the field in 2013, she has been passionate about advancing sleep health through efficient program operations, strong team collaboration, and continuous process improvement that supports both clinicians and patients.
